Stocks
Evolent Health (EVH) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -29.1% | -23.6% | 6.13% | 3.24% | -1.26% | 2.49% | ||
| Changes by years, y/y, % | -28pp | +5pp | +30pp | -3pp | -4pp | -0.8% | |||
Evolent Health. EBITDA margin, %
Evolent Health. EBITDA margin, changes, pp
Evolent Health (EVH) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -1.12% | 2.94% | 6.25% | -1.31% | 1.92% | 2.49% | |
| Changes by years, y/y, % | -1pp | +12pp | +0pp | -5pp | -2pp | |||
| Changes by quarters, q/q, % | -5pp | +4pp | +3pp | -8pp | +3pp | |||
